Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Panacea Life Sciences Holdings, Inc. (PLSH) had Receiveable Turnover of 3.90 for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$1.06M |
|
$-1.45M |
|
$0.39M |
|
$0.67M |
|
$2.11M |
|
$-1.06M |
|
$-0.39M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.06M |
|
$-0.67M |
|
16.49M |
|
16.49M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$4.64M |
|
$6.07M |
|
$12.77M |
|
$17.41M |
|
$20.39M |
|
-- |
|
$6.64M |
|
$27.04M |
|
$-9.62M |
|
$-12.64M |
|
$-9.62M |
|
18.31M |
|
| Cash Flow Statement Financials | |
$-0.36M |
|
$-0.01M |
|
$0.37M |
|
$0.10M |
|
$0.11M |
|
$0.01M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.23 |
|
-- |
|
-- |
|
-- |
|
-1.25 |
|
63.06% |
|
-100.09% |
|
-100.09% |
|
-- |
|
-136.88% |
|
-136.88% |
|
$-0.36M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.10 |
|
|
Receiveable Turnover |
3.90 |
23.07 |
|
15.03% |
|
11.44% |
|
-8.30% |
|
15.03% |
|
$-0.53 |
|
$-0.02 |
|
$-0.02 |
|